Upgrade to SI Premium - Free Trial

Formulary Update a Net Positive for Gilead Sciences (GILD), Negative for Enanta (ENTA) - RBC

August 7, 2018 10:34 AM
RBC Capital analyst Brian Abrahams said the Express Scripts formulary update is a net positive for Gilead Sciences (NASDAQ: GILD) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments FDA Trader Talk

Next Articles